Preliminary studies have shown that there is a great interest in the low molecular weight region, particularly peptides smaller than 20???kD, which may provide a novel means of diagnosing cancer and other diseases [8, 10, 11].Advances in mass spectrometry (MS) now permit the display of hundreds of small- to medium-sized peptides using only microliters of serum [12, 13].